IP Library Granted Patent US 7,524,935
Granted Patent B2
US 7,524,935 · App. 11/440,016 · Granted Apr 28, 2009

Sequences characteristic of hypoxia-regulated gene transcription

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,524,935
App. No.
11/440,016
Granted
Apr 28, 2009
Kind
B2
Abstract

There are provided polynucleotides that are modulated by hypoxic conditions. The disclosure includes such genes and proteins as well as analogs, salts and functional derivatives of such proteins, and DNA encoding such analogs, and methods of use. Methods for treating the effects of stroke, hypoxia and/or ischemia by regulating such genes or proteins are also disclosed. The presence of hypoxia or a hypoxia-associated pathology may be diagnosed by screening for the presence of at least one polynucleotide having the nucleic acid sequence according to the present invention. Methods of regulating hypoxia associated pathologies are also provided.

Claims (10)

1. An isolated molecule which comprises the antigen-binding portion of an antibody specific for a polypeptide consisting of SEQ ID NO:4.

2. An isolated molecule in accordance with claim 1 , wherein said antibody is a monoclonal antibody.

3. An isolated molecule in accordance with claim 1 , comprising a recombinant antibody.

4. An isolated molecule in accordance with claim 1 , consisting of an antibody fragment specific for a polypeptide consisting of SEQ ID NO:4.

5. An isolated molecule comprising an antibody specific for a polypeptide consisting of SEQ ID NO:4, or an antibody binding fragment of an antibody specific for a polypeptide consisting of SEQ ID NO:4.

6. An isolated molecule in accordance with claim 5 , comprising a monoclonal antibody.

7. An isolated molecule in accordance with claim 5 , comprising a recombinant antibody.

8. A molecule comprising an antibody capable of binding to a polypeptide consisting of SEQ ID NO:4, wherein said antibody is a monoclonal antibody or a recombinant antibody.

9. A molecule in accordance with claim 8 , comprising a monoclonal antibody.

10. A molecule in accordance with claim 8 , comprising a recombinant antibody.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2008
From: KALINSKI, HAGAR
To: QUARK PHARMACEUTICALS, INC.
Reel/Frame 021643/0559 →
CHANGE OF NAME Recorded Oct 7, 2008
From: QUARK BIOTECH, INC.
To: QUARK PHARMACEUTICALS, INC.
Reel/Frame 021658/0408 →